IP Library Granted Patent US 7,193,070
Granted Patent B2
US 7,193,070 · App. 10/490,594 · Granted Mar 20, 2007

Isolated DNA molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,193,070
App. No.
10/490,594
Granted
Mar 20, 2007
Kind
B2
Abstract

Disclosed herein are isolated nucleic acid molecules encoding a humanized version of a calcitonin gene-related peptide (CGRP) receptor, which comprises the G-protein coupled receptor calcitonin-receptor-like receptor (CRLR) and the receptor-activity-modifying protein 1 (RAMP1). The humanized CGRP receptors of the present invention attain pharmacological profiles similar to the wild type human receptor via modifications to the respective mammalian RAMP1 nucleotide sequence, specifically at amino acid 74. Also described are related recombinant vectors, recombinant hosts and associated methods for generating such humanized CGRP receptors. Also presented are non-human transgenic animals which express humanized RAMP1. Such animals have been engineered to provide for a CGRP pharmacological profile similar to human CGRP.

Claims (10)

1. A purified nucleic acid molecule encoding a mammalian receptor-activity modifying protein 1 which comprises a nucleotide sequence selected from the group consisting of SEQ ID NO: 1 and 3.

2. An expression vector for expressing a mammalian receptor-activity modifying protein 1 in a recombinant isolated host cell wherein said expression vector comprises a nucleic acid molecule of claim 1 .

3. A isolated host cell which expresses a recombinant mammalian receptor-activity modifying protein 1 wherein said host cell contains the expression vector of claim 2 .

4. A process for expressing a mammalian receptor-activity modifying protein 1 in a recombinant isolated host cell, comprising:

(a) transfecting the expression vector of claim 2 into a suitable host cell; and,

(b) culturing the host cells of step (a) under conditions which allow expression of said protein from said expression vector.

5. A purified mammalian receptor-activity modifying protein 1 comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 2 and 4.

6. A membrane preparation comprising the mammalian receptor-activity modifying protein 1 purified from the recombinant host cell of claim 3 .

7. The membrane preparation of claim 6 which further comprises a mammalian calcitonin-receptor-like receptor protein, such that a receptor-activity modifying protein 1-calcitonin-receptor-like receptor protein complex, in the presence of Compound 1, Compound 2, and BIBN4096BS, exhibits IC 50 values comparable to that of the human complex.

8. The membrane preparation of claim 7 wherein the calcitonin-receptor-like receptor protein is selected from the group consisting of SEQ ID NOs: 10, 12 and 14.

Assignments (5)
CHANGE OF NAME Recorded Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
MERGER Recorded Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
CHANGE OF NAME Recorded Jan 28, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023861/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2007
From: OLIVER, KEVIN R.
To: MERCK SHARP & DOHME LTD.
Reel/Frame 018852/0369 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2007
From: KANE, STEFANIE A.; SALVATORE, CHRISTOPHER A.; MALLEE, JOHN J.; KOBLAN, KENNETH S.
To: MERCK & CO., INC.
Reel/Frame 018852/0425 →